COMPARISON OF CLINICAL, METABOLIC AND ENDOCRINAL PARAMETERS OF OBESE AND LEAN POLYCYSTIC OVARY SYNDROME PATIENTS –CROSS-SECTIONAL ANALYTICAL STUDY
Obesity significantly worsens the clinical, metabolic, and endocrine manifestations of PMOS, particularly glucose metabolism and hyperandrogenism, so early identification and targeted weight-management strategies may helptoreduce metabolic complications and improve reproductive outcomes in women with PMOS.